| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |